Unknown

Dataset Information

0

A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.


ABSTRACT:

Background

Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its influence on hypertension development is poorly understood. We investigated whether fatty liver disease, as assessed by the fatty liver index, could predict the development of hypertension independently of systemic insulin resistance, inflammatory status and adipokine levels.

Methods

Prospective cohort study of 1,521 adults (484 men and 1037 women) aged 40 to 70 years without baseline hypertension examined. An equation was used to calculate fatty liver index and classify patients as follows: fatty liver index <30, no non-alcoholic fatty liver disease; fatty liver index ? 60, non-alcoholic fatty liver disease; and 30 ? fatty liver index <60, intermediate fatty liver index.

Results

During an average of 2.6 years of follow-up, 153 subjects (10.06%) developed hypertension. Fatty liver index was positively associated with baseline blood pressure, homeostasis model assessment of insulin resistance, urinary albumin/creatinine excretion, and high sensitivity C-reactive protein. After adjustment for confounding factors, including markers of insulin resistance, systemic inflammation and adiponectin levels, the odds ratio [95% confidence interval] for the incident hypertension increased in a graded manner with fatty liver index (<30 vs. 30-59 vs. ? 60 = 1 vs. 1.83 [1.16~2.88] vs. 2.09 [1.08~4.055], respectively).

Conclusions

Non-alcoholic fatty liver disease assessed by fatty liver index was an independent risk factor for hypertension. Our findings suggest that fatty liver index, a simple surrogate indicator of fatty liver disease, might be useful for identifying subjects at high risk for incident hypertension in clinical practice.

SUBMITTER: Huh JH 

PROVIDER: S-EPMC4664241 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study.

Huh Ji Hye JH   Ahn Song Vogue SV   Koh Sang Baek SB   Choi Eunhee E   Kim Jang Young JY   Sung Ki-Chul KC   Kim Eung Ju EJ   Park Jeong Bae JB  

PloS one 20151130 11


<h4>Background</h4>Although non-alcoholic fatty liver disease is the hepatic manifestation of metabolic syndrome, its influence on hypertension development is poorly understood. We investigated whether fatty liver disease, as assessed by the fatty liver index, could predict the development of hypertension independently of systemic insulin resistance, inflammatory status and adipokine levels.<h4>Methods</h4>Prospective cohort study of 1,521 adults (484 men and 1037 women) aged 40 to 70 years with  ...[more]

Similar Datasets

| S-EPMC4979827 | biostudies-other
| S-EPMC3857372 | biostudies-literature
| S-EPMC6571573 | biostudies-literature
| S-EPMC6008942 | biostudies-literature
| S-EPMC5524328 | biostudies-other
| S-EPMC8317942 | biostudies-literature
| S-EPMC8678668 | biostudies-literature
| S-EPMC6615775 | biostudies-literature
| S-EPMC6247753 | biostudies-other
| S-EPMC4130745 | biostudies-literature